BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lu AG, Feng H, Wang PXZ, Han DP, Chen XH, Zheng MH. Emerging roles of the ribonucleotide reductase M2 in colorectal cancer and ultraviolet-induced DNA damage repair. World J Gastroenterol 2012; 18(34): 4704-4713 [PMID: 23002339 DOI: 10.3748/wjg.v18.i34.4704]
URL: https://www.wjgnet.com/1007-9327/full/v18/i34/4704.htm
Number Citing Articles
1
Min Yang, Panpan Yao, Xuqiang Lang, Xue Li, Dawei Zhang. Ribonucleotide reductase subunit M2 promotes proliferation and epithelial–mesenchymal transition via the JAK2/STAT3 signaling pathway in retinoblastomaBioengineered 2021; 12(2): 12800 doi: 10.1080/21655979.2021.2001241
2
Yanjun Xu, Feng Li, Tan Wu, Yingqi Xu, Haixiu Yang, Qun Dong, Meiyu Zheng, Desi Shang, Chunlong Zhang, Yunpeng Zhang, Xia Li. LncSubpathway: a novel approach for identifying dysfunctional subpathways associated with risk lncRNAs by integrating lncRNA and mRNA expression profiles and pathway topologiesOncotarget 2017; 8(9): 15453 doi: 10.18632/oncotarget.14973
3
Justin Barnes, Betty Pat, Yuan-Wen Chen, Pamela C. Powell, Wayne E. Bradley, Junying Zheng, Amrit Karki, Xiangqin Cui, Jason Guichard, Chih-Chang Wei, James Collawn, Louis J. Dell’Italia. Whole-genome profiling highlights the molecular complexity underlying eccentric cardiac hypertrophyTherapeutic Advances in Cardiovascular Disease 2014; 8(3): 97 doi: 10.1177/1753944714527490
4
Sarah E. Huff, Jordan M. Winter, Chris G. Dealwis. Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and PresentBiomolecules 2022; 12(6): 815 doi: 10.3390/biom12060815
5
Hao Feng, Jing-kun Zhao, Tobias S Schiergens, Pu-xiongzhi Wang, Bao-chi Ou, Rami Al-Sayegh, Ming-lun Li, Ai-guo Lu, Shuai Yin, Wolfgang E Thasler. Bone marrow-derived mesenchymal stromal cells promote colorectal cancer cell death under low-dose irradiationBritish Journal of Cancer 2018; 118(3): 353 doi: 10.1038/bjc.2017.415
6
Y Aye, M Li, M J C Long, R S Weiss. Ribonucleotide reductase and cancer: biological mechanisms and targeted therapiesOncogene 2015; 34(16): 2011 doi: 10.1038/onc.2014.155
7
Noor Pratap Singh, P. K. Vinod. Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinomaMolecular Genetics and Genomics 2020; 295(3): 807 doi: 10.1007/s00438-020-01664-y
8
Gang Chen, Mingwei Yu, Jianqiao Cao, Huishan Zhao, Yuanping Dai, Yizi Cong, Guangdong Qiao. Identification of candidate biomarkers correlated with poor prognosis of breast cancer based on bioinformatics analysisBioengineered 2021; 12(1): 5149 doi: 10.1080/21655979.2021.1960775
9
MATHIAS FÜLLER, MIRIAM KLEIN, EVA SCHMIDT, CHRISTIAN ROHDE, STEFANIE GÖLLNER, ISABEL SCHULZE, JIANG QIANLI, WOLFGANG E. BERDEL, BAYRAM EDEMIR, CARSTEN MÜLLER-TIDOW, PETRA TSCHANTER. 5-Azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylationInternational Journal of Oncology 2015; 46(3): 1192 doi: 10.3892/ijo.2014.2792
10
Chi-Wei Chen, Yongming Li, Shuya Hu, Wei Zhou, Yunxiao Meng, Zongzhu Li, Yi Zhang, Jing Sun, Zhou Bo, Melvin L. DePamphilis, Yun Yen, Zhiyong Han, Wenge Zhu. DHS (trans−4,4′-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2)Oncogene 2019; 38(13): 2364 doi: 10.1038/s41388-018-0584-6
11
Chunsheng Yang, Yan Liang, Ning Liu, Meili Sun. Role of the cGAS-STING pathway in radiotherapy for non-small cell lung cancerRadiation Oncology 2023; 18(1) doi: 10.1186/s13014-023-02335-z
12
Zhenjiang Wang, Mingyi Guo, Xinbo Ai, Jianbin Cheng, Zaiwei Huang, Xiaobin Li, Yuping Chen. Identification of Potential Diagnostic and Prognostic Biomarkers for Colorectal Cancer Based on GEO and TCGA DatabasesFrontiers in Genetics 2021; 11 doi: 10.3389/fgene.2020.602922
13
Tomas Ozdian, Dusan Holub, Zuzana Maceckova, Lakshman Varanasi, Gabriela Rylova, Jiri Rehulka, Jana Vaclavkova, Hanus Slavik, Pavel Moudry, Pawel Znojek, Jarmila Stankova, Juan Bautista de Sanctis, Marian Hajduch, Petr Dzubak. Proteomic profiling reveals DNA damage, nucleolar and ribosomal stress are the main responses to oxaliplatin treatment in cancer cellsJournal of Proteomics 2017; 162: 73 doi: 10.1016/j.jprot.2017.05.005
14
Ehsan Pournoor, Zaynab Mousavian, Abbas Nowzari Dalini, Ali Masoudi-Nejad. Identification of Key Components in Colon Adenocarcinoma Using Transcriptome to Interactome Multilayer FrameworkScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59605-z
15
Chao Li, Jingfang Zheng, Si Chen, Bin Huang, Guosheng Li, Zichao Feng, Jiwei Wang, Shujun Xu. RRM2 promotes the progression of human glioblastomaJournal of Cellular Physiology 2018; 233(10): 6759 doi: 10.1002/jcp.26529
16
Abhijeet R. Patil, Ming-Ying Leung, Sourav Roy. Identification of Hub Genes in Different Stages of Colorectal Cancer through an Integrated Bioinformatics ApproachInternational Journal of Environmental Research and Public Health 2021; 18(11): 5564 doi: 10.3390/ijerph18115564
17
Zijian Zhou, Qiang Song, Yuanyuan Yang, Lujia Wang, Zhong Wu. Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-CancerCancers 2022; 14(12): 2938 doi: 10.3390/cancers14122938
18
Sergio Corrales-Guerrero, Tiantian Cui, Veronica Castro-Aceituno, Linlin Yang, Sindhu Nair, Haihua Feng, Monica Venere, Stephanie Yoon, Todd DeWees, Changxian Shen, Terence M. Williams. Inhibition of RRM2 radiosensitizes glioblastoma and uncovers synthetic lethality in combination with targeting CHK1Cancer Letters 2023; 570: 216308 doi: 10.1016/j.canlet.2023.216308
19
Prasanna Vidyasekar, Pavithra Shyamsunder, Rajpranap Arun, Rajalakshmi Santhakumar, Nand Kishore Kapadia, Ravi Kumar, Rama Shanker Verma, Zheng Li. Genome Wide Expression Profiling of Cancer Cell Lines Cultured in Microgravity Reveals Significant Dysregulation of Cell Cycle and MicroRNA Gene NetworksPLOS ONE 2015; 10(8): e0135958 doi: 10.1371/journal.pone.0135958
20
Vei Mah, Mohammad Alavi, Diana C. Márquez-Garbán, Erin L. Maresh, Sara R. Kim, Steve Horvath, Lora Bagryanova, Sara Huerta-Yepez, David Chia, Richard Pietras, Lee Goodglick, Srikumar P Chellappan. Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking StatusPLOS ONE 2015; 10(5): e0127600 doi: 10.1371/journal.pone.0127600
21
Wen‐Hui Liang, Na Li, Zhi‐Qing Yuan, Xin‐Lai Qian, Zhi‐Hui Wang. DSCAM‐AS1 promotes tumor growth of breast cancer by reducing miR‐204‐5p and up‐regulating RRM2Molecular Carcinogenesis 2019; 58(4): 461 doi: 10.1002/mc.22941
22
Sevastianos Chatzidavid, Christina-Nefeli Kontandreopoulou, Panagiotis T. Diamantopoulos, Nefeli Giannakopoulou, Panagiota Katsiampoura, Christos Stafylidis, Georgios Dryllis, Marie-Christine Kyrtsonis, Maria Dimou, Panayiotis Panayiotidis, Nora-Athina Viniou. The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic LeukemiaClinical Hematology International 2023; 5(2-3): 92 doi: 10.1007/s44228-023-00033-x
23
Urbashi Basnet, Abhijeet R. Patil, Aditi Kulkarni, Sourav Roy. Role of Stress-Survival Pathways and Transcriptomic Alterations in Progression of Colorectal Cancer: A Health Disparities PerspectiveInternational Journal of Environmental Research and Public Health 2021; 18(11): 5525 doi: 10.3390/ijerph18115525
24
Qian Yang, Mingming Qi, Yongyu Chen, Shan Tian, Fei Liao, Weiguo Dong. ASPM is a Novel Candidate Gene Associated with Colorectal Cancer Cell GrowthDNA and Cell Biology 2021; 40(7): 921 doi: 10.1089/dna.2020.6457
25
Zhipeng Zhu, Lulu Li, Jiuhua Xu, Weipeng Ye, Borong Chen, Junjie Zeng, Zhengjie Huang. Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinomaPeerJ 2020; 8: e9201 doi: 10.7717/peerj.9201
26
Lihua Zhang, Yonglong Yang, Lin Cheng, Yu Cheng, Hong-Hao Zhou, Zhi-Rong Tan. Identification of Common Genes Refers to Colorectal Carcinogenesis with Paired Cancer and Noncancer SamplesDisease Markers 2018; 2018: 1 doi: 10.1155/2018/3452739
27
Ye-han Liu, Min-min Shen, Yu-chen Wu, Kai-zhi Luo, Jian-kang Zhang, Zheng Wang, Zi-yi Chen, Jie Li, Si-yao Wu, Neng-ming Lin, Chong Zhang, Yang-ling Li. Triacanthine enhances the sensitivity of colorectal cancer cells to 5-fluorouracil by regulating RRM2Phytomedicine 2024; 126: 155204 doi: 10.1016/j.phymed.2023.155204
28
Xiang Ding, Houyu Duan, Hesheng Luo. Identification of Core Gene Expression Signature and Key Pathways in Colorectal CancerFrontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.00045
29
Cheng-Yu Jin, Liang Du, A-Han Nuerlan, Xiao-Lei Wang, Yong-Wei Yang, Rui Guo. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinomaAging 2021; 13(3): 3518 doi: 10.18632/aging.202292
30
Xin Yin, Kan Jiang, Ziyang Zhou, Hao Yu, Danfang Yan, Xingkang He, Senxiang Yan, Giselle Cerchiaro. Prognostic and Immunological Potential of Ribonucleotide Reductase Subunits in Liver CancerOxidative Medicine and Cellular Longevity 2023; 2023: 1 doi: 10.1155/2023/3878796
31
Chih-Wei Chen, Ning Tsao, Lin-Yi Huang, Yun Yen, Xiyong Liu, Christine Lehman, Yuh-Hwa Wang, Mei-Chun Tseng, Yu-Ju Chen, Yi-Chi Ho, Chian-Feng Chen, Zee-Fen Chang. The Impact of dUTPase on Ribonucleotide Reductase-Induced Genome Instability in Cancer CellsCell Reports 2016; 16(5): 1287 doi: 10.1016/j.celrep.2016.06.094
32
Md. Ariful Islam, Md. Bayazid Hossen, Md. Abu Horaira, Md. Alim Hossen, Md. Kaderi Kibria, Md. Selim Reza, Khanis Farhana Tuly, Md. Omar Faruqe, Firoz Kabir, Rashidul Alam Mahumud, Md. Nurul Haque Mollah. Exploring Core Genes by Comparative Transcriptomics Analysis for Early Diagnosis, Prognosis, and Therapies of Colorectal CancerCancers 2023; 15(5): 1369 doi: 10.3390/cancers15051369
33
Gongshen Jin, Kangwei Wang, Yonghong Liu, Xianhu Liu, Xiaojing Zhang, Hao Zhang. Proteomic Level Changes on Treatment in MCF-7/DDP Breast Cancer Drug- Resistant CellsAnti-Cancer Agents in Medicinal Chemistry 2020; 20(6): 687 doi: 10.2174/1871520620666200213102849
34
Xueting Hu, Jian Zhou, Yan Zhang, Yindi Zeng, Guitao Jie, Sheng Wang, Aixiang Yang, Menghui Zhang. Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experimentsFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.942454